https://www.intelliatx.com/publications/a-single-administration-of-crispr-cas9-lipid-nanoparticles-achieves-robust-and-persistent-in-vivo-genome-editing/ 2020-02-18T21:36:40+00:00 https://www.intelliatx.com/publications/rescue-of-amyloid-deposition-phenotype-after-single-treatment-crispr-cas9-gene-editing-in-a-humanized-mouse-model-of-attr/ 2020-02-18T21:38:17+00:00 https://www.intelliatx.com/publications/engineering-of-highly-functional-and-specific-transgenic-t-cell-receptor-tcr-t-cells-using-crispr-mediated-in-locus-insertion-combined-with-endogenous-tcr-knockout/ 2020-02-18T21:39:31+00:00 https://www.intelliatx.com/publications/development-of-ntla-1001-first-in-class-lnp-crispr-cas9-mediated-genome-editing-therapeutic-for-the-treatment-of-attr/ 2020-02-18T21:40:21+00:00 https://www.intelliatx.com/publications/delivering-on-the-therapeutic-potential-of-crispr-cas9-development-of-an-lnp-mediated-genome-editing-therapeutic-for-the-treatment-of-attr/ 2020-02-18T21:41:14+00:00 https://www.intelliatx.com/publications/crispr-cas9-mediated-targeted-insertion-of-human-f9-achieves-therapeutic-circulating-protein-levels-in-mice-and-non-human-primates/ 2020-02-18T21:42:06+00:00 https://www.intelliatx.com/publications/crispr-cas9-mediated-gene-knockout-to-address-primary-hyperoxaluria/ 2020-02-18T21:42:55+00:00 https://www.intelliatx.com/publications/development-of-ntla-2001-a-crispr-cas9-genome-editing-therapeutic-for-the-treatment-of-attr/ 2020-02-18T21:43:47+00:00 https://www.intelliatx.com/publications/using-lipid-nanoparticles-to-efficiently-deliver-crispr-cas9-for-genome-editing/ 2020-02-18T21:44:52+00:00 https://www.intelliatx.com/publications/crispr-cas9-mediated-gene-knockout-to-address-primary-hyperoxaluria-2/ 2020-02-18T21:46:19+00:00 https://www.intelliatx.com/publications/developing-next-generation-engineered-tcr-t-cells-with-crispr/ 2020-02-18T21:48:32+00:00 https://www.intelliatx.com/publications/in-vivo-delivery-of-crispr-cas9-to-the-liver-using-lipid-nanoparticles-enables-gene-knockout-across-multiple-targets-in-rodent-and-non-human-primates/ 2020-02-18T22:12:50+00:00 https://www.intelliatx.com/publications/supra-therapeutic-levels-of-transgene-expression-achieved-in-vivo-by-crispr-cas9-mediated-targeted-gene-insertion/ 2020-02-18T22:16:51+00:00 https://www.intelliatx.com/publications/in-silico-biochemical-and-cell-based-integrative-genomics-identifies-precise-crispr-cas9-targets-for-human-therapeutics/ 2020-02-18T22:19:36+00:00 https://www.intelliatx.com/publications/in-vivo-gene-knockout-followed-by-targeted-gene-insertion-results-in-simultaneous-reduced-mutant-protein-levels-and-durable-transgene-expression/ 2020-02-18T22:22:26+00:00 https://www.intelliatx.com/publications/enhanced-tgtcr-t-cell-product-attributes-through-process-improvement-of-crispr-cas9-engineering/ 2020-05-12T10:00:12+00:00 https://www.intelliatx.com/publications/validation-of-crispr-cas9-off-target-discovery-profiles-from-in-silico-prediction-cell-based-and-biochemical-based-assays-with-targeted-off-target-sequencing/ 2020-05-12T20:30:52+00:00 https://www.intelliatx.com/publications/in-vivo-model-development-for-genome-edited-t-cell-therapeutics/ 2020-05-14T13:17:22+00:00 https://www.intelliatx.com/publications/crispr-cas9-mediated-liver-gene-knockout-of-klkb1-to-treat-hereditary-angioedema/ 2020-05-15T13:30:27+00:00 https://www.intelliatx.com/publications/a-modular-crispr-cas9-genome-editing-platform-for-durable-therapeutic-knockout-and-targeted-gene-insertion-applications/ 2020-12-05T14:54:56+00:00 https://www.intelliatx.com/publications/ntla-5001-a-t-cell-product-candidate-with-crispr-based-targeted-insertion-of-a-high-avidity-natural-wt1-specific-tcr-shows-efficacy-in-in-vivo-models-of-aml-and-all/ 2020-12-05T15:00:17+00:00 https://www.intelliatx.com/publications/crispr-cas9-mediated-targeted-gene-insertion-of-serpina1-to-treat-alpha-1-antitrypsin-deficiency-aatd/ 2020-12-12T14:00:28+00:00 https://www.intelliatx.com/publications/ntla-2002-crispr-cas9-mediated-gene-knockout-of-klkb1-for-hereditary-angioedema/ 2021-02-27T23:22:14+00:00 https://www.intelliatx.com/publications/intellia-presents-preclinical-proof-of-concept-for-crispr-based-in-vivo-editing-of-bone-marrow-at-keystone-esymposium/ 2021-03-11T22:52:28+00:00 https://www.intelliatx.com/publications/in-vivo-genome-editing-of-hematopoietic-stem-and-progenitor-cells/ 2021-03-15T16:17:51+00:00 https://www.intelliatx.com/publications/special-edition-expanding-intellias-toolbox-with-base-editing/ 2021-03-25T16:30:27+00:00 https://www.intelliatx.com/publications/development-of-in-vivo-systemic-crispr-based-therapeutics/ 2021-05-11T22:15:12+00:00 https://www.intelliatx.com/publications/crispr-cas9-mediated-targeted-gene-insertion-of-serpina1-to-treat-alpha-1-antitrypsin-deficiency/ 2021-05-11T22:15:21+00:00 https://www.intelliatx.com/publications/avoiding-unintended-genome-editing-for-crispr-cas9-therapeutics/ 2021-05-11T21:16:27+00:00 https://www.intelliatx.com/publications/in-vivo-crispr-cas9-editing-of-the-ttr-gene-by-ntla-2001-in-patients-with-transthyretin-amyloidosis/ 2021-06-26T15:37:39+00:00